tirzepatide,weight loss;High Quality and High Purity Peptide;hot selling;safe transportation

Connect With:Domi

WhatsApp:+86 18331965818

Email: domi@xtjytech.com

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

Benefits

Helps slow food leaving your stomach

Helps prevent your liver from making too much sugar

Helps the pancreas produce more insul when your blood sugar levels are high

Can help control blood glucose

Can reduce hyperglycemia, especially after meals

Can reduce fasting insul and fasting glucose

Can reduce hemoglobin A1c

Can decrease appetite and caloric intake, while inhibiting weight gain

Has been shown to lower triglyceride levels and oxidative stress from high LDL

Has been shown to help induce weight loss in obese patients with higher dosing

Helps decrease leptin and increase leptin sensitivity

Can increase the conversion of white fat to brown fat

On the one hand, Tirzepatide activates GLP-1 receptors, which can regulate insulin secretion and glucagon release, strengthen blood glucose control, and also delay gastric emptying and suppress appetite.

On the other hand, activation of GIP receptors can reduce diet and increase calorie expenditure. At the same time, it can directly act on white adipose tissue, helping to improve the insulin sensitivity and fat buffering capacity of tissue cells, and improve blood flow and storage capacity. 

Applicable  P opulation :

Improve blood sugar in adults with type 2 diabetes.
As a weight loss drug for adults who are obese (BMI 30 or above) or overweight (BMI 27 or above but with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or high cholesterol), with Manage your weight by reducing dietary calories and increasing exercise.

Should be stored in the refrigerator at 2°C to 8°C, away from light.

If required, each single-dose pen can be stored unrefrigerated at a temperature not exceeding 30°C for up to 21 days, but once stored at room temperature it should not be returned to the refrigerator. If not used within 21 days after removal from the refrigerator, it should be discarded. Do not freeze tilpotide and if frozen, do not use.